Loading clinical trials...
Loading clinical trials...
Safety and Therapeutic Efficacy of DC Vaccine Combined With Cytokine-induced Killer Cells in Patients With Extensive-Stage Small- Cell Lung Cancer: a Phase I/II Study
Conditions
Interventions
adenovirus-transfected autologous DC vaccine plus CIK cells
Start Date
August 1, 2014
Primary Completion Date
August 1, 2016
Completion Date
November 1, 2016
Last Updated
February 23, 2016
Lead Sponsor
Affiliated Hospital to Academy of Military Medical Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions